GLAXOSMITHKLINE PHARMACEUTICALS LTD.
Market Cap.(`)
|
50554.15 Cr.
|
P/BV
|
30.22
|
Book Value (`)
|
98.74
|
52 Week High/Low ( ` )
|
3148/1921
|
FV/ML
|
10/1
|
P/E(X)
|
54.50
|
Book Closure
|
30/05/2025
|
EPS (`)
|
54.75
|
Div Yield (%)
|
1.81
|
(` in Crs.)
You can view the
Consolidated
Cash Flow
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | 1255.19 | 959.80 | 841.49 | 2475.65 | 723.10 |
| | | | | |
Net CashFlow From Operating Activities | 1289.91 | 582.02 | 484.23 | 810.75 | 577.93 |
Net Cash Used In Investing Activities | -45.81 | 8.71 | 807.85 | -405.51 | 418.59 |
Net Cash Used From Financing Activities | -769.42 | -561.50 | -1543.32 | -524.24 | -696.14 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | 474.68 | 29.23 | -251.25 | -119.00 | 300.38 |
Cash And Cash Equivalents Begin of Year | 64.17 | 34.94 | 286.19 | 405.19 | 104.81 |
Cash And Cash Equivalents End Of Year | 538.85 | 64.17 | 34.94 | 286.19 | 405.19 |